Elli Karagianni, is SNE/ Scientific Project Officer at the Innovative Medicines Initiative2 JU (IMI2 JU), a public- private partnership for health between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA)
Elli is responsible for developing and implementing the Patient Engagement Strategy in IMI2 JU which aims to enhance the quality and relevance of the IMI programme from the patient perspective through early and meaningful engagement.
After obtaining a BA (hons) in Political Sciences from the University of Hull, UK she was admitted in 2002 to the National School of Public Administration in Greece (ESDD), and in 2004 she was appointed as public administrator to the Greek Ministry of Health where she gained first-hand experience and insights of the planning and implementation of health and social policies at the national level.
Elli has held administrative positions in the public hospital sector where she became involved in different projects such as the Greek Health Atlas project; a perpetual system of data used for measuring and assessing the adequacy, effectiveness and efficiency of the country’s health services.
She holds a Master’s degree (Master à finalité recherche) from the School of Advanced Studies in Social Sciences (Ecole des Hautes Etudes en Sciences Sociales, EHESS) in Paris, France, where she conducted a qualitative field research studying the evolution of patients’ rights in Europe, and the different levels of patient involvement in healthcare decision-making .
Elli also holds a joint Master’s degree in Economics and Human Sciences from the École Normale Supérieure Paris-Saclay (ENS Paris-Saclay) and the University of Paris 1 Panthéon-Sorbonne.
